From lab result to bedside decision, in under two minutes.
DxTiba reads the antibiotic susceptibility results your hospital lab already produces and turns them into a ranked, guideline-aligned prescribing recommendation. Streamline the ward round, drive guideline concordance, and give clinicians a clear answer exactly where and when it is needed.
Decision support, not diagnosis. The clinician always decides.
Isolate
Klebsiella pneumoniaeESBL+
Susceptibility
MeropenemS
AmikacinS
CiprofloxacinI
CeftriaxoneR
Recommendation
1st Meropenem 1g IV q8h
Result → recommendation1 min 12 s
Modernize the antibiotic decision.
Help your team decide faster and prescribe at the top of their training, through a single clear screen instead of a stack of guideline PDFs: organism, susceptibility, ranked options, dosing.
Explore every feature1.8 minMedian turnaround
96%Guideline concordance
134Results processed
Recommendations issuedMon – Sun
Built on the standards your clinicians already follow
Kenya NAP-AMRNational treatment guidelines
WHO AWaReAccess · Watch · Reserve
CLSI / EUCASTSusceptibility breakpoints
GLASS-readySurveillance-shaped data
Isolate
Klebsiella pneumoniaeESBL+
Susceptibility
MeropenemS
AmikacinS
CiprofloxacinI
CeftriaxoneR
Recommendation
1st Meropenem 1g IV q8h
Result → recommendation1 min 12 s
Real-time support, when time matters most.
Empower your frontline teams by giving them the answer at the point of care: which antibiotic, at what dose, for how long, and when to de-escalate. It is the information your clinicians need, at the exact time and place they need it.
“The result is already in the lab. What costs the patient time is the lookup in between.”
Linus Anyega MorekaFounder, DxTiba · BPharm · JOOTRH Kisumu
Your content, digitally optimized.
Your clinicians need more than off-the-shelf logic to do their best work. DxTiba is configured to the hospital it runs in: your formulary, your local antibiogram, the protocols your stewardship committee signed off on.
And because the logic is rules-based rather than a black-box model, every recommendation traces back to the guideline clause it came from.
What DxTiba does and does not doIsolate
Klebsiella pneumoniaeESBL+
Susceptibility
MeropenemS
AmikacinS
CiprofloxacinI
CeftriaxoneR
Recommendation
1st Meropenem 1g IV q8h
Result → recommendation1 min 12 s
The gap we are closing.
20–30
Minutes of manual guideline lookup, per patient
The step DxTiba removes
72 hrs
Typical cycle from sample to a settled decision
Today, without decision support
<2 min
From AST result to guideline-aligned recommendation
The target DxTiba is built to hit
Partners & ecosystem
The institutions and standards we build against.
Kenya NAP-AMR guidelines
Guideline framework
Every recommendation DxTiba surfaces is mapped to Kenya's National Action Plan on Antimicrobial Resistance and national treatment guidelines, the standards clinicians are already held to.
WHO AWaRe & GLASS
Guideline framework
Recommendations are classified against the WHO AWaRe categories, and our data model is designed to report cleanly into GLASS-style surveillance from day one.
Pharmacy and Poisons Board
Regulatory pathway
As a rules-based decision-support tool rather than a diagnostic device, DxTiba is being built to a clear, documentable regulatory pathway with Kenya's medicines regulator.
Partner with us.
Hospital partnerships are open and we are actively looking for our first three. If you run a ward, a lab or a stewardship committee, this space is yours.
A word from our founder.
Coming together to slow antimicrobial resistance.
We are looking for Kenyan referral hospitals willing to run a short, low-risk pilot on a single ward, and for clinicians willing to tell us where the workflow really breaks.